Management of Portal Vein Thrombosis in a Postpartum Patient Using Combined Endovascular Therapy and Anticoagulation

Shannon Chu1, Fahad Farooq1, Zohaib Khan1

  • 1Radiology, State University of New York Upstate Medical University, Syracuse, USA.

Cureus
|February 9, 2026
PubMed

Portal vein thrombosis (PVT) is a rare but potentially life-threatening condition in the postpartum period. We present the case of a 25-year-old female who developed extensive thrombosis involving the portal vein, superior mesenteric vein, and splenic vein 13 days after an at-home vaginal delivery complicated by manual placenta extraction performed at a hospital. She presented with progressive abdominal pain and was found to have postpartum endometritis, retained products of conception, and ascites. Laboratory evaluation revealed leukocytosis and mild hepatic enzyme elevation, with a largely negative thrombophilia workup. Given the extensive thrombosis involving the portal vein, superior mesenteric vein, inferior mesenteric vein, and splenic vein, accompanied by ascites and multiple risk factors, she underwent urgent catheter-directed thrombolysis and mechanical thrombectomy in addition to systemic anticoagulation. Post-procedural imaging confirmed significant restoration of portal venous flow. The patient was transitioned to oral anticoagulation and discharged in stable condition. This case highlights the importance of early recognition and multidisciplinary management of postpartum PVT. In patients with extensive clot burden or risk factors for failed recanalization, endovascular therapy combined with anticoagulation may offer a superior outcome to anticoagulation alone.

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
269
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
478
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K